General / Press Release
Change in SEQENS’ shareholding structure
SEQENS is now stronger, more focused and positioned as one of the world’s leading players in pharmaceutical solutions and specialty ingredients 3 new…
Read moreNewsroom
General
New investments in China
On Thursday, April 6, 2023, during the plenary session of the Franco-Chinese Business Council in Beijing and in the presence of the President of…
Read more
Events / General
Seqens Group Opens Flagship Pharmaceutical R&D Center in Boston
The Seqens group has announced today that it has opened a state-of-the-art, 1,500 sqm R&D center in Devens, Mass., to serve as one…
Read more
General
Seqens enhances its manufacturing capacities in pharma polymers & lipids at Aramon’s Plant, in France.
SEQENS is committed, through its Drug Delivery Business Line, to accelerate its capabilities in Lipids & Polymers manufacturing on one of our cGMP Plant,…
Read more
General
Seqens group at DCAT Week 2023
From March 20 to 23, 2023, a delegation representing all the group’s pharmaceutical activities attended the DCAT week in New York. More than a…
Read more
General
Seqens chooses to reshore Paracetamol production in France : work on the future plant has begun.
Back in June 2020, Emmanuel Macron announced his will to restore France’s health sovereignty. Following this, Seqens has chosen to reshore a part of…
Read more
General
SEQENS Turku Plant (Finland) reaches 100% Renewable Energy and zero direct carbon emissions
This achievement reflects SEQENS strong commitment to reduce its environmental and carbon footprint in line with the Group ESG Program. SEQENS, an integrated…
Read more
Events
DCAT 2022: a success for Seqens group
From March 21 to 24, 2022, a delegation representing all of the group’s pharmaceutical activities took part in the DCAT event in New York.
Read more
Press Release
SEQENS Makes Multi-Million-Dollar Investment in U.S. R&D Laboratory
Investment Signals Major Commitment to U.S. Market and Builds on Merger with Contract Development and Manufacturing Organization Wavelength Pharmaceuticals. investment in Devens SEQENS,…
Read more
General
Meeting with Virginie Tarlet for the International Women’s Day
For the International Women’s day, SEQENS highlights the career path of inspiring women working within the group. Meet Virginie Tarlet Roussillon Lab manager. What is…
Read more
General
Meeting with Aïna Queiroz for the International Women’s Day
For the International Women’s day, SEQENS highlights the career path of inspiring women working within the group. Meet Aïna Queiroz, Head of innovation and scientific…
Read more